Terms: = Sarcomas AND SDHD, PGL1, 6392, ENSG00000204370, PGL, SDH4, CBT1, O14521 AND Treatment
4 results:
1. Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome.
Settas N; Faucz FR; Stratakis CA
Mol Cell Endocrinol; 2018 Jul; 469():107-111. PubMed ID: 28739378
[TBL] [Abstract] [Full Text] [Related]
2. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.
Fanelli M; Hattinger CM; Vella S; Tavanti E; Michelacci F; Gudeman B; Barnett D; Picci P; Serra M
Curr Cancer Drug Targets; 2016; 16(3):261-74. PubMed ID: 26548759
[TBL] [Abstract] [Full Text] [Related]
3. Connecting molecular pathways to hereditary cancer risk syndromes.
Testa JR; Malkin D; Schiffman JD
Am Soc Clin Oncol Educ Book; 2013; ():81-90. PubMed ID: 23714463
[TBL] [Abstract] [Full Text] [Related]
4. The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications.
Stratakis CA; Carney JA
J Intern Med; 2009 Jul; 266(1):43-52. PubMed ID: 19522824
[TBL] [Abstract] [Full Text] [Related]
